Sept 4, 2013. 1  Diamondback 360 coronary orbital atherectomy system. 2  Crowns. 3  Accessories. 4  Instructions for Use. 5  Prescriptive Information.
https://csi360.com/products/diamondback-360-coronary-orbital-atherectomy-system/
Indications: The Diamondback 360® Coronary Orbital Atherectomy System (OAS) is a percutaneous orbital atherectomy system indicated to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for PTCA or stenting due to de novo, severely calcified coronary artery lesions.
https://csi360.com/products/diamondback-360-coronary-orbital-atherectomy-system/
Both are approved for use in atherectomy of the peripheral vasculature and are not approved for use in coronary, carotid, iliac, or renal arteries. Directional atherectomy is considered a minimally invasive treatment that removes plaque and restores blood flow in the native artery. Besides removing plaque from the body, the other advantages of directional atherectomy include lack of barotrauma, which decreases the risk of neointimal hyperplasia and lesser risk of dissection.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274140/
The Diamondback 360 ® Coronary Orbital Atherectomy System (OAS) is the only device indicated to treat severely calcified coronary lesions. Orbital Atherectomy reduces severe calcium, enabling successful stent deployment to help optimize stent expansion and percutaneous coronary intervention (PCI) outcomes.
https://csi360.com/products/diamondback-360-coronary-orbital-atherectomy-system/
Abstract. 1  Atherectomy is a procedure which is performed to remove atherosclerotic plaque from diseased arteries. Atherosclerotic plaques are localized in either coronary or peripheral arterial vasculature and may have different characteristics depending on the texture of the plaque.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274140/
Orbital atherectomy (OA) is another atherectomy device being used for plaque modification, to reduce the total atheroma burden, to change the arterial compliance, and to decrease the vessel-wall trauma.50 The Diamondback 360° OAS is very similar to RA devices, as it uses a crown that is equivalent to the RA burr.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274140/
SilverHawk and TurboHawk directional atherectomy systems. 1  The SilverHawk and TurboHawk plaque excision systems are the two US Food and Drug Administration-approved directional atherectomy devices in use today.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274140/
CSI is defining Orbital Atherectomy with the first evidence-based vessel preparation treatment for severely calcified coronary lesions, which enables successful stent deployment, leading to safe and effective PCI outcomes with low re-admission rates. Coronary arterial calcium can cause complications when treating coronary artery disease (CAD).
https://csi360.com/products/diamondback-360-coronary-orbital-atherectomy-system/
Diamondback 360 Coronary Orbital Atherectomy System indication & important safety information Indication: The DIAMONDBACK 360® Coronary Orbital Atherectomy Systems (OAS) are percutaneous orbital atherectomy systems indicated to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for PTCA or stenting due to de novo, severely calcified coronary artery lesions.
https://csi360.com/products/diamondback-360-coronary-orbital-atherectomy-system/
Atherectomy has been used effectively in treatment of both coronary and peripheral arterial disease. Atherectomy devices are designed differently to either cut, shave, sand, or vaporize these plaques and have different indications. In this article, current atherectomy devices are reviewed.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274140/
what is atherectomy
Atherectomy is a procedure which is performed to remove atherosclerotic plaque from diseased arteries.